South Korea · Delayed Price · Currency is KRW Lunit Company Description
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea.
It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer.
The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations and with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development.
Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2013 |
| Industry | Software - Application |
| Sector | Technology |
| CEO | Beomseok Brandon Suh |
Contact Details
Address: K-Square Gangnam 2 Seoul South Korea | |
| Phone | 82 2 2138 0827 |
| Website | lunit.io |
Stock Details
| Ticker Symbol | 328130 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7328130000 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Beomseok Brandon Suh | Chief Executive Officer |
| Hyeonseong Park | Chief Financial Officer |